On the other hand, it is possible to investigate whether pre- and combined estradiol administration to these glycoalkaloids leads to a change in Akt and ER expressions, and how it affects other endometrial cancer cell lines, Ishikawa and HEC-1A. The gene discussed is ESR1; the disease is endometrial cancer.